Safety surveillance study of influenza virus vaccine live intranasal (Fluenz) in children in England during early 2016 influenza season

Trial Profile

Safety surveillance study of influenza virus vaccine live intranasal (Fluenz) in children in England during early 2016 influenza season

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2017

At a glance

  • Drugs Influenza virus vaccine live (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 19 Sep 2017 Design keyword (prospective), subject gender (male and female) and actual patient number are assumed.
    • 19 Sep 2017 New trial record
    • 30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top